Frank Lanza's most recent trade in Harpoon Therapeutics Inc was a trade of 15,000 Common Stock done . Disclosure was reported to the exchange on Jan. 7, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Harpoon Therapeutics Inc | Lanza Frank | Principal Fin. & Acctng Ofc. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2024 | 15,000 | 18,362 (0%) | 0% | 0 | Common Stock | |
| Harpoon Therapeutics Inc | Frank Lanza | Principal Fin. & Acctng Ofc. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 65,000 | 65,000 | - | - | Employee Stock Option (right to buy) | |
| Harpoon Therapeutics Inc | Frank Lanza | Principal Fin. & Acctng Ofc. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2022 | 86,438 | 86,438 | - | - | Employee Stock Option (right to buy) |